Featured Research

from universities, journals, and other organizations

Gene therapy study seeks to improve brain function in Alzheimer's disease

Date:
January 26, 2010
Source:
Emory University
Summary:
Alzheimer's disease (AD) researchers are testing the effectiveness of gene therapy for the first time to treat patients with this common brain disease. A total of 12 institutions are participating in a nationwide study to test the experimental medication, CERE-110.

Alzheimer's disease (AD) researchers are testing the effectiveness of gene therapy for the first time to treat patients with this common brain disease. Emory University is one of 12 institutions participating in a nationwide study to test the experimental medication, CERE-110.

Related Articles


The Phase 2 clinical trial seeks to enroll a total of 50 study participants with mild to moderate AD.

Previously studied in animals and in a small study to assess safety in humans, CERE-110 appears to induce long-term production of Nerve Growth Factor (NGF) by brain cells. NGF is a naturally occurring protein that helps nerve cells, or neurons, survive in the brain. These neurons produce a chemical, acetylcholine, which plays a vital role in memory and cognitive function.

"Since NGF supports the survival and function of the neurons that deteriorate in people with Alzheimer's disease, we hope to slow the worsening of their symptoms with this new therapy," says James Lah, MD, associate professor of neurology, Emory University School of Medicine and lead investigator of the study at Emory.

During the Phase 2 clinical trial, a neurosurgeon will inject CERE-110 directly into the nucleus basalis of Meynert (NBM) of the brain, an area where neuron death occurs in AD. CERE-110 packages the gene for NGF within a shell from the adeno-associated virus. Putting an extra copy of the NGF gene into cells drives them to make more NGF. The original virus is not known to cause disease -- and as an extra precaution, most of the insides of the virus are removed.

"Adeno-associated viral vectors like the one used in this study have proven safe in extensive animal testing, as well as several other human trials for neurodegenerative diseases," says Nicholas Boulis, MD, assistant professor, department of neurosurgery, Emory University School of Medicine. Boulis has previously conducted neurosurgical adeno-associated gene therapy and is performing the surgery in the Emory study.

A Phase 1 study was conducted where the treatment was found to be generally safe and well tolerated. The 10 subjects underwent cognitive testing, measures of activities of daily living, and MRI and PET (positron emission tomography) scans. Researchers observed increases in brain metabolism in several cortical regions of the brain at six months and 12 months in some of the participants, as compared to other severity-matched individuals with AD, suggesting a potential reversal of patterns typically observed in AD. With follow up ranging from six months to more than four years post-treatment, there have been no side effects thought to be caused by CERE-110.

In previous studies, CERE-110 reversed brain degeneration in aged animals and in animal models intended to create cholinergic degeneration, a feature that characterizes changes in early AD. The overall study is conducted by the Alzheimer's Disease Cooperative Study (ADCS), a nationwide consortium of research centers and clinics supported by the National Institute on Aging (NIA), National Institutes of Health, and coordinated by the University of California San Diego. Ceregene, Inc., the study sponsor, is a San Diego-based biotechnology company providing CERE-110 for the study.


Story Source:

The above story is based on materials provided by Emory University. Note: Materials may be edited for content and length.


Cite This Page:

Emory University. "Gene therapy study seeks to improve brain function in Alzheimer's disease." ScienceDaily. ScienceDaily, 26 January 2010. <www.sciencedaily.com/releases/2010/01/100125174922.htm>.
Emory University. (2010, January 26). Gene therapy study seeks to improve brain function in Alzheimer's disease. ScienceDaily. Retrieved October 26, 2014 from www.sciencedaily.com/releases/2010/01/100125174922.htm
Emory University. "Gene therapy study seeks to improve brain function in Alzheimer's disease." ScienceDaily. www.sciencedaily.com/releases/2010/01/100125174922.htm (accessed October 26, 2014).

Share This



More Health & Medicine News

Sunday, October 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins